ArticleCirculation2017

Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease.

Ben A Kappel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.